Arovella Therapeutics Limited (ASX:ALA)
0.0890
0.00 (0.00%)
Aug 25, 2025, 3:59 PM AEST
Arovella Therapeutics Revenue
In the fiscal year ending June 30, 2025, Arovella Therapeutics had annual revenue of 3.44M AUD with 76.22% growth. Arovella Therapeutics had revenue of 830.00 in the half year ending June 30, 2025, a decrease of -96.85%.
Revenue
3.44M
Revenue Growth
+76.22%
P/S Ratio
30.77
Revenue / Employee
127.41K
Employees
27
Market Cap
105.87M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 3.44M | 1.49M | 76.22% |
Jun 30, 2024 | 1.95M | 497.46K | 34.20% |
Jun 30, 2023 | 1.45M | 1.16M | 391.76% |
Jun 30, 2022 | 295.81K | -693.91K | -70.11% |
Jun 30, 2021 | 989.72K | -261.71K | -20.91% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.00B |
Mesoblast | 9.16M |